Insider · CIK 0001862050

Hussain Iqbal J

CIK 0001862050 Name as filed on the most recent filing

Filed as Hussain Iqbal J (16)

22 transaction lines · from 16 filings · filed 2021-06-04 to 2026-02-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

22 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-02-02 S, Open-market sale Centessa Pharmaceuticals plcCNTA 979,657, disposed Open Form 4 filing 0001470831-26-000092
2026-01-30 S, Open-market sale Centessa Pharmaceuticals plcCNTA 25,261, disposed Open Form 4 filing 0001470831-26-000092
2025-11-17 S, Open-market sale Centessa Pharmaceuticals plcCNTA 165,835, disposed Open Form 4 filing 0001470831-25-000344
2025-10-15 S, Open-market sale Centessa Pharmaceuticals plcCNTA 134,439, disposed Open Form 4 filing 0001470831-25-000263
2025-09-15 S, Open-market sale Centessa Pharmaceuticals plcCNTA 131,101, disposed Open Form 4 filing 0001470831-25-000200
2025-09-10 S, Open-market sale Centessa Pharmaceuticals plcCNTA 440,000, disposed Open Form 4 filing 0001470831-25-000189
2025-09-09 S, Open-market sale Centessa Pharmaceuticals plcCNTA 400,102, disposed Open Form 4 filing 0001470831-25-000189
2025-08-15 S, Open-market sale Centessa Pharmaceuticals plcCNTA 103,380, disposed Open Form 4 filing 0001847903-25-000137
2025-07-15 S, Open-market sale Centessa Pharmaceuticals plcCNTA 89,567, disposed Open Form 4 filing 0001847903-25-000117
2025-06-24 S, Open-market sale Centessa Pharmaceuticals plcCNTA 168,218, disposed Open Form 4 filing 0001847903-25-000114
2025-05-01 S, Open-market sale Centessa Pharmaceuticals plcCNTA 4,354, disposed Open Form 4 filing 0001847903-25-000064
2025-04-28 S, Open-market sale Centessa Pharmaceuticals plcCNTA 29,132, disposed Open Form 4 filing 0001847903-25-000061
2025-04-25 S, Open-market sale Centessa Pharmaceuticals plcCNTA 50,526, disposed Open Form 4 filing 0001847903-25-000061
2025-03-17 S, Open-market sale Centessa Pharmaceuticals plcCNTA 98,697, disposed Open Form 4 filing 0001847903-25-000040
2025-02-18 S, Open-market sale Centessa Pharmaceuticals plcCNTA 2 lines 97,065, disposed Open Form 4 filing 0001847903-25-000033
2025-01-15 S, Open-market sale Centessa Pharmaceuticals plcCNTA 91,740, disposed Open Form 4 filing 0001847903-25-000009
2024-12-16 S, Open-market sale Centessa Pharmaceuticals plcCNTA 1,273,756, disposed Open Form 4 filing 0001847903-24-000183
2022-10-03 S, Open-market sale Centessa Pharmaceuticals plcCNTA 18,024, disposed Open Form 4 filing 0001847903-22-000064
2022-09-30 S, Open-market sale Centessa Pharmaceuticals plcCNTA 15,151, disposed Open Form 4 filing 0001847903-22-000064
2021-06-02 P, Open-market purchase Centessa Pharmaceuticals plcCNTA 2 lines 170,000, acquired Open Form 4 filing 0000899243-21-022067

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 20
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. HUSSAIN IQBAL J, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001862050

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.